For corporate information:

Pharmacyclics LLC
1000 Gateway Blvd South
San Francisco, CA 94080
Phone: 1-408-215-3000

Janssen Biotech, Inc.
800 Ridgeview Drive
Horsham, PA 19044

For IMBRUVICA® By Your Side Patient Support Program information:

Phone: 1-888-YourSide (1-888-968-7743)
Monday through Friday, 8:00 AM to 8:00 PM ET

For medical information inquiries.

For medical information inquiries about IMBRUVICA® or to report a possible adverse event or product quality complaint, please contact Pharmacyclics Medical Information by using one of the following two methods:

Phone: 1-877-877-3536

To contact us by email, please fill out the form located here:

You are encouraged to report side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Pharmacyclics, an AbbVie Company, may collect your personal data through your online and offline interactions with us, including your contact, demographic, geolocation, and health-related data. We may also collect your online usage data automatically through cookies and similar technologies. We use this data for several purposes, such as to provide you with and improve our programs, services, and products, customize your experiences, and for research and analytics. We retain your personal data for as long as necessary to fulfill these purposes or to comply with our record retention obligations. We do not sell your personal data but may use and disclose your personal data with marketing and advertising partners to deliver you ads based on your interests inferred from your activity across other unaffiliated sites and services (“online targeted advertising”) and for website analytics. To opt out of the use or disclosure of your personal data for online targeted advertising or for website analytics, go to Your Privacy Choices on our website. For more information on the personal data categories we collect, the purposes for their collection, our disclosures to third parties, your data subject rights, and our data retention criteria, visit our Privacy Notice.

Through my submission of the program enrollment form, I consent to the collection, use, and disclosure of my personal health data, as described in the Privacy Notice above and in AbbVie’s Privacy Notice in the How We May Disclose Personal Data section. My consent is required to process sensitive personal data under certain privacy laws, and I have the right to withdraw my consent by visiting Your Privacy Choices on AbbVie’s website.

IMBRUVICA® (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at